Treatments · Entity Annotation Prototype (beta)

5articles mentioning treatments

18treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: TACE ×

TACE

This treatment is selected. Its supporting articles are shown below.

TACE5

Articles mentioning TACE

5 articles · page 1 of 1

P57 An audit of transarterial chemoembolisation (TACE) and transarterial embolisation (TAE) for hepatocellular carcinoma (HCC): pathology, procedures, complications and outcomes – a single regional centre study over four years

gutjnl · abstract · 2025-10-06 · 8 matching annotations

95.4%

TACE TAE Doxorubicin Cancer Research UK

…ted 5 year survival of only 15% [BSG 2024, Cancer Research UK]. TACE and TAE are treatment options for intermediate BCLC stage disea…

IDDF2026-ABS-0170 Spatial multi-omic profiling maps hypoxia-driven pro-fibrotic SPP1+ macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma

gutjnl · abstract · 2026-06-26 · 4 matching annotations

79.7%

Transarterial chemoembolisation TACE hepatocellular carcinoma HCC

…Background Transarterial chemoembolisation (TACE) is a standard first-line therapy for intermediate-to-adv…

4CPS-161 Prognostic value of first trans arterial chemoembolisation with hepatoma arterial-embolisation prognostic score in hepatocellular carcinoma: real-world data

ejhpharm · abstract · 2026-03-18 · 4 matching annotations

79.7%

Trans arterial chemoembolisation TACE HCC hepatocellular carcinoma

…Background and Importance Trans arterial chemoembolisation (TACE) is the standard treatment for intermediate-stage hepatoc…

Clarifying the clinical role and implementation boundaries of the clinical-radiological model for TACE-treated hepatocellular carcinoma

gutjnl · abstract · 2026-04-24 · 1 matching annotations

77.1%

transarterial chemoembolisation TACE hepatocellular carcinoma Warsaw

…iological model (CRM) for hepatocellular carcinoma treated with transarterial chemoembolisation (TACE).1 The multinational cohort, the external validation in W…

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study

gutjnl · abstract · 2026-03-30 · 1 matching annotations

81.3%

TACE TACE therapy hepatocellular carcinoma HCC The Cancer Genome Atlas TCGA

…non-invasively predict the prognosis of HCC patients treated by TACE therapy.…